Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Frequency ExchangeFRECF 8 Price-to-Tangible-Book is 62.60 as of Jul. 29, 2026, which is 278% above its 10-year median of 16.58. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.09 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 700 Medical Devices & Instruments companies, Frequency Exchange ranks worse than 142857% on this metric.
The historical rank and industry rank for Frequency Exchange's Price-to-Tangible-Book or its related term are showing as below:
During the past 6 years, Frequency Exchange's highest Price to Tangible Book Ratio was 67.50. The lowest was 2.71. And the median was 16.58.
FRECF's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.515 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Frequency Exchange Price-to-Tangible-Book Related Terms
Frequency Exchange Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Frequency Exchange's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRECF vs ABT, SYK, MDT: Price-to-Tangible-Book Comparison
For the Medical Devices subindustry, Frequency Exchange's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange Price-to-Tangible-Book vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Frequency Exchange (FRECF) has a Price-to-Tangible-Book of 62.60 as of Jul. 29, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Frequency Exchange and its competitors. This is 278% above median its historical median of 16.58. Over the past decade, Frequency Exchange's Price-to-Tangible-Book has ranged from 2.71 to 67.50. According to the industry distribution chart, Frequency Exchange ranks #999999 out of 700 companies in the Medical Devices & Instruments industry.
Is Frequency Exchange's Price-to-Tangible-Book too high?
Frequency Exchange's current Price-to-Tangible-Book of 62.60 is 278% above median its 10-year median of 16.58. Over the past 10 years, this metric has ranged from a low of 2.71 to a high of 67.50. The Medical Devices & Instruments industry median Price-to-Tangible-Book is 2.52. Frequency Exchange's value of 62.60 is 2389.1% above this industry median. Based on the distribution chart, Frequency Exchange ranks #999999 out of 700 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's Price-to-Tangible-Book compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #999999 out of 700 companies for Price-to-Tangible-Book. This places Frequency Exchange in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.52. Frequency Exchange's value of 62.60 is 2389.1% above this benchmark. Historically, Frequency Exchange's own Price-to-Tangible-Book has ranged from 2.71 to 67.50 over the past decade. While the company's 10-year median is 16.58 vs. the industry median of 2.52, Frequency Exchange has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Devices & Instruments company?
The median Price-to-Tangible-Book among Medical Devices & Instruments companies is 2.52, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frequency Exchange's current Price-to-Tangible-Book of 62.60 is 2389.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Frequency Exchange and its competitors. For the Medical Devices & Instruments industry, the median Price-to-Tangible-Book is 2.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current Price-to-Tangible-Book is 62.60, which is 278% above median its own 10-year median of 16.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.09, compared to a current price of $0.19 — trading 108.7% above its estimated fair value. The current Price-to-Tangible-Book is 62.60, which is 278% above median its 10-year median of 16.58 and 2389.1% above the Medical Devices & Instruments industry median of 2.52. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current Price-to-Tangible-Book is 62.60 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.19 is trading 108.7% above its estimated GF Value™ of $0.09.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
Price-to-Tangible-Book: 62.60 (278% above median its 10-year median of 16.58)
GF Value™: $0.09 vs. price of $0.19 (108.7% above fair value)
Industry Position: 2389.1% above the Medical Devices & Instruments median (#999999 of 700)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 
